Literature DB >> 29936127

mTORC1 pathway in DNA damage response.

Yinxing Ma1, Yegor Vassetzky1, Svetlana Dokudovskaya2.   

Abstract

Living organisms have evolved various mechanisms to control their metabolism and response to various stresses, allowing them to survive and grow in different environments. In eukaryotes, the highly conserved mechanistic target of rapamycin (mTOR) signaling pathway integrates both intracellular and extracellular signals and serves as a central regulator of cellular metabolism, proliferation and survival. A growing body of evidence indicates that mTOR signaling is closely related to another cellular protection mechanism, the DNA damage response (DDR). Many factors important for the DDR are also involved in the mTOR pathway. In this review, we discuss how these two pathways communicate to ensure an efficient protection of the cell against metabolic and genotoxic stresses. We also describe how anticancer therapies benefit from simultaneous targeting of the DDR and mTOR pathways.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anticancer drugs; Autophagy; DNA damage response; GATOR1; Mitochondria; PI3K-AKT; SESTRINS; mTORC1 pathway; p53

Mesh:

Substances:

Year:  2018        PMID: 29936127     DOI: 10.1016/j.bbamcr.2018.06.011

Source DB:  PubMed          Journal:  Biochim Biophys Acta Mol Cell Res        ISSN: 0167-4889            Impact factor:   4.739


  36 in total

1.  Association analysis between feed efficiency and expression of key genes of the avTOR signaling pathway in meat-type ducks.

Authors:  Lei Yang; Tingting He; Yuan Xu; He Zang; Jiafa Wang; Zhiqiang Lin; Sihua Jin; Zhaoyu Geng
Journal:  Mol Biol Rep       Date:  2019-05-28       Impact factor: 2.316

Review 2.  So close, no matter how far: multiple paths connecting transcription to mRNA translation in eukaryotes.

Authors:  Boris Slobodin; Rivka Dikstein
Journal:  EMBO Rep       Date:  2020-08-16       Impact factor: 8.807

Review 3.  Targeting the PI3K pathway and DNA damage response as a therapeutic strategy in ovarian cancer.

Authors:  Tzu-Ting Huang; Erika J Lampert; Cynthia Coots; Jung-Min Lee
Journal:  Cancer Treat Rev       Date:  2020-04-10       Impact factor: 12.111

Review 4.  Crosstalk between the mTOR and DNA Damage Response Pathways in Fission Yeast.

Authors:  John-Patrick Alao; Luc Legon; Charalampos Rallis
Journal:  Cells       Date:  2021-02-02       Impact factor: 6.600

5.  NMR- and MD simulation-based structural characterization of the membrane-associating FATC domain of ataxia telangiectasia mutated.

Authors:  Munirah S Abd Rahim; Yevhen K Cherniavskyi; D Peter Tieleman; Sonja A Dames
Journal:  J Biol Chem       Date:  2019-03-13       Impact factor: 5.157

6.  Deregulation of AKT-mTOR Signaling Contributes to Chemoradiation Resistance in Lung Squamous Cell Carcinoma.

Authors:  Changxian Shen; Duan-Liang Shyu; Min Xu; Linlin Yang; Amy Webb; Wenrui Duan; Terence M Williams
Journal:  Mol Cancer Res       Date:  2022-03-01       Impact factor: 6.333

7.  Unraveling the mechanisms of chemotherapy-induced damage to human primordial follicle reserve: road to developing therapeutics for fertility preservation and reversing ovarian aging.

Authors:  Katarzyna J Szymanska; Xiujuan Tan; Kutluk Oktay
Journal:  Mol Hum Reprod       Date:  2020-08-01       Impact factor: 4.025

8.  Functional crosstalk between mTORC1/p70S6K pathway and heterochromatin organization in stress-induced senescence of MSCs.

Authors:  Hailong Liu; Biao Huang; Shaolong Xue; Kin Pong U; Lai Ling Tsang; Xiaohu Zhang; Gang Li; Xiaohua Jiang
Journal:  Stem Cell Res Ther       Date:  2020-07-13       Impact factor: 6.832

Review 9.  Caffeine as a tool for investigating the integration of Cdc25 phosphorylation, activity and ubiquitin-dependent degradation in Schizosaccharomyces pombe.

Authors:  John P Alao; Per Sunnerhagen
Journal:  Cell Div       Date:  2020-06-29       Impact factor: 5.130

Review 10.  SOX2 and p53 Expression Control Converges in PI3K/AKT Signaling with Versatile Implications for Stemness and Cancer.

Authors:  Thorsten Schaefer; Rebekah Steiner; Claudia Lengerke
Journal:  Int J Mol Sci       Date:  2020-07-11       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.